학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 50건 | 목록 1~20
Academic Journal
Sabatine, Marc SWiviott, Stephen DScirica, Benjamin MInzucchi, SilvioKeech, AnthonyMcGuire, Darren KSmith, Steven RSatlin, AndrewBrown, ConvilleBudaj, AndrzejCorbalan, RamonDwyer, JamieGarcia-Castillo, ArmandoGupta, MilanHamm, ChristianKaplan, LeeLeiter, Lawrence ANicolau, Jose CarlosOude Ophuis, TonRay, KauskiRuda, MikhailSpinar, JindrichWeissman, NeilWhite, Harvey DAmerena, JArstall, MColquhoun, DJayasinghe, RLee, ALehman, RMoses, RProietto, JPurnell, PWaites, JBlombery, PCross, DWorthley, Md'Emden, MSelvanayagam, JOqueli, REWhelan, AGarrahy, Pde Looze, FNinio, DHorowitz, JWilliam, MSuranyi, MWittert, GLe May, MPandey, ASVizel, SLabonte, RBeaudry, YFortin, CBell, AKouz, SSt-Amour, ÉBata, ISt Maurice, FChehayeb, RConstance, CWong, GHess, ALiutkus, JPoirier, PTeitelbaum, IBerlingieri, JCha, JHartleib, MHeffernan, MTwum-Barima, DPandith, VAronson, RGoldenberg, RAjala, BJain, ARoss, SBajaj, HKhandwala, HYared, ZGupta, NBédard, JWharton, SBlouin, FSavard, DShukla, DCobos, JGodoy, GPerez, LPincetti, CSaavedra Guajardo, VVarleta, PConejeros, CLanas, FBayram Llamas, ECardona Muñoz, EGarcia, RGarza Ruiz, JLlamas Esperon, GLopez Rosas, EMelendez Mier, GRamos, GHart, HScott, DTernouth, IBenatar, JElliott, JCutfield, RManning, PWilliams, MFerrier, KScott, RWilson, SLeikis, RNirmalaraj, BKKrzyżagórska, EMiękus, PBronisz, MMirek-Bryniarska, EŁanda, KStasiewski, AŻechowicz, TZytkiewicz-Jaruga, DKorecki, JOgórek, MPawłowicz, LPiepiorka, MSkierkowska, JStankiewicz, ASzyprowska, EWitek, RBochenek, AKończakowski, PWojnowski, ŁWujkowski, MCymerman, KKorzeniak, RMąder, PMikłaszewicz, BStachlewski, PGoch, APomiećko, WSkórski, MRomanowski, LJusiak, KLaskowska-Derlaga, EBijata-Bronisz, RKaźmierczak, JGoldberg, RHenderson, DKorban, ERohr, KClaxton, EWeiss, RAngiolillo, DBoccalandro, FChu, KThorn, ERandhawa, PSingh, NBittar, GGuarnieri, TSaeed, SSharma, SShepard, MFrench, WDesai, PBernstein, RRogers, WSingal, RSchneider, RShanes, JOng, SCondit, JDonahoe, SBrill, DEinhorn, DEbrahimi, RLabroo, AGraf, RScott, JHoekstra, JJetty, PLuckasen, GO'Donnell, PGonte, WPomposini, DQuadrel, MKoren, MSchlager, DSchramm, ESingal, DLupovitch, SSoni, ASeigel, PRoberts, JSoufer, JReza, SQuinlan, EMoretto, TFirst, BKhan, MChilka, SColfer, HTeklinski, AWallace-Wilding, KEllison, HMuse, DAronoff, SHiggins, APatel, SElinoff, VKarim, AAwasty, VChuang, RRoseman, HDugano-Daphnis, PAlbert, MSheikh, KBays, HKaster, SGoldstein, MRubino, DCalatayud, GSnyder, HWilliams, THershon, KHagan, MIsserman, SKahn, BAnderson, JGimness, MPRaisinghani, AChristina, MRaikhel, MGillespie, EPortnay, EHeiman, MQureshi, MLee, JBlonder, RCucher, FMiller, GKotlaba, DCornett, GBeavins, JAugenbraun, CReinhardt, SBartkowiak, A, JrSalacata, ABlevins, TBenjamin, SDiener, JGeorge, WBarker, BRichwine, RBaldari, DAlfieri, ABarreto, AZhang, LShah, RHendrix, ESubramaniyam, VHurley, SLillestol, MO'Donoghue, MShayani, SRyan, ECall, RZemel, LChang, AKivitz, AFreyne, BBland, VShore, KMostel, EUzoaga, EAndrawis, NGabra, NGhitis, ASabatino, KBrowder, DVarma, SSmith, SFink, RAycock, GR, JrDoty, WDAlfonso, TEshaghian, SKarlsberg, RZarich, SLandau, CMcKenzie, MKrause, RDavis, WHaddad, TVoyce, SAlford, CLeDoux, JO'Dea, DPark, JAroda, VGetaneh, AGraham, BBhagwat, RKorn, DRuoff, GWiseman, ALieber, IFialkow, JGonzalez-Campoy, JMBayron, CBertolet, BLash, JGerrish, CRobertson, DRosenfeld, JSeidner, MAgaiby, JSilverfield, JSugimoto, DLubin, BAlhaddad, MLui, HLakin, GChokshi, SDonovan, DFelten, WMinton, SKimmelstiel, CKuvin, JStill, CByars, WTalano, JDesai, VBradley, AJ, IIIBaker, SChane, MMercado, ABaron, SHarris, BMayer, NConcha, MCarr, KChaykin, LWillis, JClay, AFenstad, EFurda, JPeterson, PChang, MAronne, LJones, DPrashad, RBenson, MStegemoller, RLongshaw, KSaleh, JJennings, WDetweiler, RViswanath, DPatel, RLederman, SWeinstein, DKorabathina, RSingh, VRosen, JEstevez, RLevin, PMcNeill, RKalen, VReed, JAshley, RHerman, LTsai, YKayne, DWhite, AHussain, ITami, LCohen, KRobinson, JFuchs-Ertman, DPlatt, GBelardo, LReddy, RRosendorff, CSaba, FPowell, SAnderson, KAbidi, MRezkalla, SParaschos, AWilson, JMoursi, MShah, ANadar, VStonesifer, LBialow, MCannon, KEllison, WStedman, MBrown, JHarper, WLucas, KJDiGiovanna, MRodbard, HBiscoveanu, MDavis, CHall, JLittlefield, RGorman, TKereiakes, DChang, FMTatu, HCheung, DKaine, JKnutson, TLogemann, TPueblitz, GBianco, JHenson, BNeustel, MGelernt, MNelson, WMoriarty, KLefebvre, GMaw, KRink, LBehn, PStuddard, HArgoud, GO'Connor, TKrichmar, PRaad, GPereles-Ortiz, JSorli, CCohen, APettis, KCavanaugh, BPhillips, CWahlen, JRadin, DRider, JKosinski, ELeimbach, WOdhav, AHakas, JTan, AHowell, MWombolt, DFishman, NShah, PWylie, PArauz-Pacheco, CCavale, AGeorge, AKroll, RKrantzler, JTahirkheli, NJabro, MNewell, MMullen, PGencheff, NMeli, JVora, KKotek, LPyzdrowski, KPaez, HMoran, JTannenbaum, ADeck, KBusch, RLevinson, LAzizad, MWhitaker, JFox, BHuffman, CAshraf, MDiogo, JKushner, RTallet, JChannamsetty, VSuh, DAtieh, MNavas, JYoung, VShaw, SDor, IDuffy, BRubin, PLewis, DKaye, WBenton, RBurbano, JHotchkiss, DMagno, AAlberton, ACollins, JAlvarado, OStich, MMahal, SLiu, JHong, MDy, JBlock, BLamantia, JPritchard, JDavis, MSrivastava, SBilazarian, SRosario, RMcCartney, MBlumberg, VRajan, RMartin, EWright, SBrinson, CJohnston, JGraves, MDominguez, MMcKenzie, WAbadier, RTran, CCastello, RMorawski, EWhite, JMorris, FPerez, ATrueba, PSanchez, MAndersen, JKastelic, RKhan, JRodriguez, HIzquierdo, WMatias, AEssandoh, LInce, CBohula, Erin AInzucchi, Silvio EKeech, Anthony CKanevsky, EstellaMurphy, Sabina ADwyer, Jamie POphuis, Ton OudeRay, Kausik KPatel, TusharMiao, WenfengPerdomo, CarlosFrancis, BruceDhadda, ShobhaBonaca, Marc PRuff, Christian T
In The Lancet 24-30 November 2018 392(10161):2269-2279
Academic Journal
J. DormandyJ. BetteridgeK. BirkelandB. CharbonnelD. EcklandE. ErdmannA. GolayL. KorányiR. HeineM. LaaksoM. Massi BenedettiM. MokáňI. MoulesA. NorkusV. PiragsT. PodarJ. RungbyA. ScheenW. ScherbaumG. SchernthanerO. SchmitzA. SkeneJ. ŠkrhaU. SmithR. SulcaiteM. TanJ. TatoňP. ThorsbyB. CharbonelP. LefebvreG. MurrayE. StandlR. WilcoxL. WilhelmsenP. BrunettiM. BrousserL. NorgrenD. ThomasG. BelcherL. BennettE. LöschelD. OakleyH. ThomasR. UrquhartA. WeaverE. AllaireH. ChabriatR. ChoussatL. ErhardtM. FiorrelliD. GrayA. HallidayB. NorrvingE. OstorH. ParssonC. SchneiderT. SzajewskiA. AshanK. BaigJ. BaronA. CookeA. HarcombeA. MccanceJ. RowleyA. StaniforthJ. WalshP. BolgerC. LambertJ. KinleyE. LoschelA. van Troostenburg de BruynA. CairnsA. CharlesworthR. EdwardsA. KemptonJ. PowditchS. SteadC. VincentM. NowakowskiW. NugentG. TaylorG. BiesenbachP. Bratusch MarrainH. DrexelT. EggerF. HoppichlerG. KaczerovskyB. LudvikJ. PatschK. PossnigR. PragerT. WascherJ. DaubresseJ. DucobuF. FeryC. HerbautF. NobelsH. PenninckxL. Van GaalA. KlimovicovaM. KvapilV. LoykováJ. OlsovskyF. PatekJ. SkrhaA. SmahelovaZ. VlasakovaI. BaumbachC. ChristensenK. ClemmensenJ. FaberH. LervangS. MadsbadA. PrangeB. ThorsteinssonT. LaksJ. AirasR. AntikainenP. EbelingJ. ErikssonH. HaapamäkiT. HakamäkiP. HimanenM. HuttunenS. JunnilaP. KuusistoA. Latva NevalaS. LaukkanenH. LevänenP. SalmelaH. SödervikA. StrandbergJ. TuomilehtoM. VanhalaJ. AttaliF. BerthezeneJ. BlickleJ. BrunC. BrunetièreG. CharpentierJ. CourregesB. EstourH. Hanaire BroutinV. KerlanA. LaoufiC. Le DevehatP. RitzM. RodierP. RogerG. SlamaD. VannereauO. ZieglerP. AlgenstaedtB. AllolioJ. AnselA. BarakatA. BauschertJ. BlumeG. BöhmH. EtzrodtK. EvenT. EversmannM. FreudenbergD. GrünekleeM. HanefeldH. HascheR. Herold BeifussK. HeunB. HirschhäuserH. IlgeA. KellnerG. KlausmannE. KlennerA. KüppersU. MaassP. MayerM. NauckU. OrdaP. PriebeJ. SauterJ. SchallerW. SchlauchJ. SchmeckW. SchmidtG. WoywodT. ZenderM. BaranyiJ. BárdosT. BölcsvölgyiA. BruncsákE. DömötörM. DudásP. FaludiI. FöldesiJ. FövényiL. GeröT. HidvégiL. JánoskutiG. JermendyE. JuhászS. Kassay FarkasL. KautzkyZ. KerényiA. KovácsG. NeuwirthJ. PátkayÉ. PéterfaiG. PogátsaF. PoórG. RumiC. RuzsaE. SasváryK. SimonA. SomogyiJ. TakácsG. TamásM. TarkóF. TárnokB. ValentaG. VándorfiP. VörösA. AielloP. Cavallo PerinG. CicioniG. CrepaldiF. FolliC. FossatiR. ManuntaC. MarinoG. SeghieriR. SivieriS. SquatritoA. BogdanovaB. JejereI. LagzdinaI. LeitaneA. LejnieksC. PiragsI. RezgaleJ. SokolovaA. ValtereA. BaubinieneJ. DanileviciusN. JurgevicieneG. KazanaviciusA. PliuskysV. UrbanaviciusE. VaranauskieneR. ZalinkevisiusM. BlonkJ. JonkerG. StormsJ. SwartA. van de WielT. ClaudiD. DrybekkC. FossumJ. HalseH. IstadH. LangbergS. SkeieH. ThordarssonS. VaalerT. Wessel AasR. AdamiecE. Bandurska StankiewizA. BochenekL. CeremuzyńskiM. Chmielnicka PruszczynskaH. FuchsZ. GasiorM. GrzywaR. JunikK. JusiakI. KinalskaA. KlysiakM. KozinaJ. LobaG. Majcher WitczakK. MarkiewiczA. NowakowskiG. PacykR. PetrykaG. PinisM. Polaszewska MuszynskaP. RomańczukL. RomanowskiE. Semetkowska JurkiewiczA. StankiewiczZ. StepieńC. StrugalaA. SwatkoZ. SzybińskiJ. TatońB. Wierusz WysockaE. Wilejto CierpiszM. WojciechowskaD. Zytkiewicz JarugaB. KrahulecE. MartinkaP. PontuchM. PorubskáK. RašlováI. TkáčV. UličianskyJ. VozárU. AdamssonP. AnderssonH. BrandströmA. HänniP. HellkeV. HillörnL. HulthénA. JönssonI. LagerL. LarssonE. Löfsjögard NilssonA. NorrbyT. NystromA. OdénB. PolhemG. RoseG. RüterD. UrsingR. GaillardP. GerberH. GrafE. Nützi ConstamF. AbourawiT. AkinteweJ. AndrewsS. AtkinS. BeerD. BhatnagerJ. BodanskyC. BodmerL. BorthwickA. BoultonJ. ClarkA. CollierD. DarkoM. DaviesJ. DeanT. FiadC. FoxB. FrierS. GilbeyR. GregoryC. HardistyS. HurelA. JacksonP. JenningsA. JohnsonC. JohnstonS. JonesD. KerrC. KessonA. KrentzG. LeeseD. LevyA. MacleodK. MacleodD. MatthewsM. McintyreB. MillwardD. NagiJ. OchoaB. O'MalleyM. PageS. PageJ. PetrieJ. RecklessD. RobertsonJ. RolandM. SampsonI. ScobieP. SharpK. ShawM. SmallN. VaughanJ. VoraJ. WeaverJ. WildingT. Williams
Dormandy, J A, Charbonnel, B, Eckland, D J, Erdmann, E, Massi-Benedetti, M, Moules, I K, Skene, A M, Tan, M H, Lefebvre, P J, Murray, G D, Standl, E & Wilcox, R G 2005, 'Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial', Lancet, vol. 366, no. 9493, pp. 1279-1289. https://doi.org/10.1016/S0140-6736(05)67528-9
Dormandy, J A, Charbonnel, B, Eckland, D J, Erdmann, E, Massi-Benedetti, M, Moules, I K, Skene, A M, Tan, M H, Lefebvre, P J, Murray, G D, Standl, E, Wilcox, R G, Wilhelmsen, L, Betteridge, J, Birkeland, K, Golay, A, Heine, R J, Koranyi, L, Laakso, M, Mokan, M, Norkus, A, Pirags, V, Podar, T, Scheen, A, Scherbaum, W, Schernthaner, G, Schmitz, O, Skrha, J, Smith, U & Taton, J 2005, 'Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial', The Lancet, vol. 366(9493), pp. 1279-1289.
Book
Encyclopedia of Molecular Cell Biology and Molecular Medicine ISBN: 9783527600908
Academic Journal
Kowal K; Institute of Biological Bases of Animal Production, University of Life Sciences in Lublin, Akademicka 13 St., 20-950, Lublin, Poland.; Tkaczyk-Wlizło A; Institute of Biological Bases of Animal Production, University of Life Sciences in Lublin, Akademicka 13 St., 20-950, Lublin, Poland.; Jusiak M; Institute of Biological Bases of Animal Production, University of Life Sciences in Lublin, Akademicka 13 St., 20-950, Lublin, Poland.; Grzybowska-Szatkowska L; Department of Radiotherapy, Medical University of Lublin, Chodźki 7, 20-093, Lublin, Poland.; Ślaska B; Institute of Biological Bases of Animal Production, University of Life Sciences in Lublin, Akademicka 13 St., 20-950, Lublin, Poland. brygida.slaska@up.lublin.pl.
Publisher: Springer Country of Publication: England NLM ID: 9514582 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-3883 (Electronic) Linking ISSN: 12341983 NLM ISO Abbreviation: J Appl Genet Subsets: MEDLINE
Academic Journal
Padash-Barmchi M; Department of Zoology, Cell and Developmental Biology, University of British Columbia, Vancouver, Canada BC V6T 1Z3.; Browne KSturgeon KJusiak BAuld VJ
Publisher: Company of Biologists Country of Publication: England NLM ID: 0052457 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-9137 (Electronic) Linking ISSN: 00219533 NLM ISO Abbreviation: J Cell Sci Subsets: MEDLINE
Academic Journal
Wierzchowski M; Department of Chemical Technology of Drugs, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznan, Poland. Electronic address: mwierzch@ump.edu.pl.; Sobotta LSkupin-Mrugalska PKruk JJusiak WYee MKonopka KDüzgüneş NTykarska EGdaniec MMielcarek JGoslinski T
Publisher: Elsevier Country of Publication: United States NLM ID: 7905788 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3344 (Electronic) Linking ISSN: 01620134 NLM ISO Abbreviation: J Inorg Biochem Subsets: MEDLINE
Academic Journal
Nicholls SJ; Victorian Heart Institute, Monash University, Melbourne, VIC, Australia.; Pavo I; Eli Lilly, Indianapolis.; Bhatt DL; Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York.; Buse JB; University of North Carolina, Chapel Hill.; Del Prato S; Interdisciplinary Research Center 'Health Science,' Sant'Anna School of Advanced Studies, Pisa, Italy.; Kahn SE; Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle.; Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland.; McGuire DK; University of Texas Southwestern Medical Center, Dallas.; Parkland Health and Hospital System, Dallas.; Miller D; Eli Lilly, Indianapolis.; Nauck MA; Diabetes, Endocrinology, and Metabolism Section, Department of Medicine, St. Josef-Hospital, Katholisches Klinikum Bochum, Ruhr University of Bochum, Bochum, Germany.; Institute for Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.; Nishiyama H; Eli Lilly, Indianapolis.; Nissen SE; Cleveland Clinic Coordinating Center for Clinical Research (C5 Research), Cleveland Clinic, Cleveland.; Department of Medicine, Cleveland Clinic, Cleveland.; Sattar N; School of Cardiovascular Medicine and Metabolic Health, University of Glasgow, Glasgow, United Kingdom.; Weerakkody G; Eli Lilly, Indianapolis.; Wiese RJ; Eli Lilly, Indianapolis.; Zinman B; Lunenfeld-Tanenbaum Research Institute, University of Toronto, Toronto.; Mount Sinai Hospital, University of Toronto, Toronto.; Zoungas S; Victorian Heart Institute, Monash University, Melbourne, VIC, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.; Basile J; Medical University of South Carolina, Charleston.; Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC.; Davies MJ; Diabetes Research Centre, University of Leicester, Leicester, United Kingdom.; National Institute for Health and Care Research Leicester Biomedical Research Centre, Leicester, United Kingdom.; Giorgino F; Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Bari, Italy.; Kellerer M; Department of Medicine 1, Marienhospital Stuttgart, Stuttgart, Germany.; Tübingen University Hospital, Tübingen, Germany.; Ji L; Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing.; Varkonyi T; Department of Internal Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.; Menon V; Cleveland Clinic Coordinating Center for Clinical Research (C5 Research), Cleveland Clinic, Cleveland.; Department of Medicine, Cleveland Clinic, Cleveland.; Broder JC; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.; Monash University Clinical Trials Centre, Monash University, Melbourne, VIC, Australia.; Herschtal A; Monash University Clinical Trials Centre, Monash University, Melbourne, VIC, Australia.; D'Alessio D; Duke University Medical Center, Durham, NC.
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Academic Journal
Musical Education / Edukacja Muzyczna; 2023, Vol. 18, p343-347, 5p
Academic Journal
Publisher: Polskie Towarzystwo Mikrobiologów [etc.] Country of Publication: Poland NLM ID: 7610362 Publication Model: Print Cited Medium: Print ISSN: 0137-1320 (Print) Linking ISSN: 01371320 NLM ISO Abbreviation: Acta Microbiol Pol Subsets: MEDLINE
Academic Journal
Bohula EA; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Wiviott SD; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; McGuire DK; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Inzucchi SE; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Kuder J; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Im K; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Fanola CL; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Qamar A; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Brown C; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Budaj A; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Garcia-Castillo A; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Gupta M; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Leiter LA; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Weissman NJ; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; White HD; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Patel T; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Francis B; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Miao W; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Perdomo C; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Dhadda S; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Bonaca MP; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Ruff CT; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Keech AC; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Smith SR; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Sabatine MS; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Scirica BM; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Academic Journal
Fulcher G; The Royal North Shore Hospital and University of Sydney, Sydney, Australia.; Matthews DR; Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK.; Perkovic V; The George Institute for Global Health, The Royal Prince Alfred Hospital, and University of Sydney, Sydney, Australia.; de Zeeuw D; Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Mahaffey KW; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Mathieu C; Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium.; Woo V; Endocrinology Section, Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.; Wysham C; Washington State University, Spokane, WA, USA.; Capuano G; Janssen Research & Development, LLC, Raritan, NJ, USA.; Desai M; Janssen Research & Development, LLC, Raritan, NJ, USA.; Shaw W; Janssen Research & Development, LLC, Raritan, NJ, USA.; Vercruysse F; Janssen Research & Development, Beerse, Belgium.; Meininger G; Janssen Research & Development, LLC, Raritan, NJ, USA.; Neal B; The George Institute for Global Health, The Royal Prince Alfred Hospital, and University of Sydney, Sydney, Australia.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Jusiak, K.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어